Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005095 · ClinicalTrials.gov registry record
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
A clinical trial of Ovarian Cancer and Endometrial Cancer, sponsored by Northwestern University.
- Recruiting
- Registry status
- 6,000
- Enrollment target
- 1
- Study location
NCT00005095: Recruiting study of Ovarian Cancer and Endometrial Cancer, sponsored by Northwestern University.
NCT00005095 is a study of Ovarian Cancer and Endometrial Cancer that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 6,000 participants, above the 710-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (745% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00005095, a study of Ovarian Cancer and Endometrial Cancer, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- 6,000 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: To improve strategies for detection and prevention of early-stage disease. PURPOSE: This research study is collecting specimens and data to develop better methods for early detection and prevention of ovarian cancer among the high risk population and those who have the disease.
Primary Outcome
To identify markers to allow for presymptomatic testing for ovarian and other gynecological malignancies
Conditions Studied
Interventions
- PROCEDURE Surgery
- OTHER Ca-125
- OTHER screening questionnaire administration
Study Locations (1)
Illinois
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,000 participants |
| Start Date | 2000-03 |
| Est. Completion | 2040-12 |
What NCT00005095 shows while recruiting
NCT00005095 is an observational study that tracks outcomes without assigning an intervention. Its 6,000 participants enrollment target places it among the larger protocols in the corpus, above the 710-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (745% higher).
The record links to 9 conditions, with Ovarian Cancer appearing as the primary indexed condition, and to 3 interventions - of which Surgery is the first listed.
NCT00005095 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00005095 about?
NCT00005095 is a clinical study titled "Specimen and Data Study for Ovarian Cancer Early Detection and Prevention". RATIONALE: To improve strategies for detection and prevention of early-stage disease. PURPOSE: This research study is collecting specimens and data to develop better methods for early detection and prevention of ovarian cancer among the high risk population and those who have the disease.
What is the current status of trial NCT00005095?
This trial is currently recruiting. The enrollment target is 6,000 participants. The study started on 2000-03. Estimated completion is 2040-12.
What conditions does trial NCT00005095 study?
This clinical trial studies the following conditions: Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Sarcoma, Fallopian Tube Cancer.
What interventions are being tested in trial NCT00005095?
The interventions under investigation include: Surgery (PROCEDURE), Ca-125 (OTHER), screening questionnaire administration (OTHER).
Who is sponsoring clinical trial NCT00005095?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00005095 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ovarian Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00005095's enrollment target sits among peer trials
6,000 8th of 322 higher than 315 of 322 other Ovarian Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ovarian Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
RECRUITING · Phase 1
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer
RECRUITING
-
The Better, Harder, Faster, Stronger Study
RECRUITING
-
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00280202 · 6,000 participants
Detection of Genetic Markers of Lung Cancer
- NCT03127631 · 6,000 participants · NA
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
- NCT03539705 · 6,000 participants
Food Allergy Registry at a Single Site
- NCT04324619 · 6,000 participants · NA
iLookOut for Child Abuse: Micro-learning to Improve Knowledge Retention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia